Publication | Closed Access
Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
83
Citations
11
References
2013
Year
Omalizumab shows excellent efficacy and safety profile in a large series of CSU patients in real-life practice. This drug will contribute to settle the debt with CSU patients contributing to restore their quality of life.
| Year | Citations | |
|---|---|---|
Page 1
Page 1